Abstract
We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis.
Cite
CITATION STYLE
Song, W., van den Berg, E., Kwee, T. C., Jutte, P. C., Cleton-Jansen, A.-M., Bovée, J. V. M. G., & Suurmeijer, A. J. (2018). Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis. Clinical Sarcoma Research, 8(1). https://doi.org/10.1186/s13569-018-0104-z
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.